Mechanisms of Multidrug Resistance in Cancer Chemotherapy

Mechanisms of Multidrug Resistance in Cancer Chemotherapy

Cancer is one of the main causes of death worldwide. Despite the significant development of methods of cancer healing during the past decades, chemotherapy still remains the main method for cancer treatment. Depending on the mechanism of action, commonly used chemotherapeutic agents can be divided i...

Full description

Bibliographic Details
Main Authors:	Karol Bukowski, Mateusz Kciuk, Renata Kontek
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Series:	International Journal of Molecular Sciences
Subjects:	cancer multidrug resistance chemotherapeutics inhibitors P-glycoprotein drug metabolism
Online Access:	https://www.mdpi.com/1422-0067/21/9/3233

Similar Items

Reversal of Ovarian Cancer Cell Lines Multidrug Resistance Phenotype by the Association of Apiole with Chemotherapies
by: Carolina Afonso de Lima, et al.
Published: (2020-10-01)

Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines
by: Edina Karai, et al.
Published: (2020-04-01)

Novel Heat Shock Protein 90 Inhibitors Suppress P-Glycoprotein Activity and Overcome Multidrug Resistance in Cancer Cells
by: Jelena Dinić, et al.
Published: (2019-09-01)

Identification and characterization of a novel mechanism of multidrug resistance in tumour cells
by: Wang, Ying, 1958-
Published: (1998)

Targeting multidrug resistance in cancer by natural chemosensitizers
by: Ahmed R. Hamed, et al.
Published: (2019-01-01)

Overcoming Multidrug Resistance in Human Cancer Cells by Natural Compounds
by: Tomohiro Nabekura
Published: (2010-05-01)

Role of multidrug transporters in neurotherapeutics
by: Jose Manna, et al.
Published: (2009-01-01)

Glicoproteína-P, resistência a múltiplas drogas (MDR) e relação estrutura-atividade de moduladores P-glycoprotein and multidrug resistance: structure-activity relationships of modulators
by: Paula C. Huber, et al.
Published: (2010-01-01)

The role of photodynamic therapy on multidrug resistant breast cancer
by: Eric Chekwube Aniogo, et al.
Published: (2019-04-01)

Development of a Novel Quinoline Derivative as a P-Glycoprotein Inhibitor to Reverse Multidrug Resistance in Cancer Cells
by: Yuanyuan Zhou, et al.
Published: (2019-10-01)

Inhibitory Effects of Salinispora-derived Metabolites Against Multidrug Resistance: An In-silico Study
by: Morteza Ghandadi
Published: (2020-07-01)

Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target
by: Theo Battista, et al.
Published: (2020-04-01)

Taxifolin Resensitizes Multidrug Resistance Cancer Cells via Uncompetitive Inhibition of P-Glycoprotein Function
by: Hsiu-Ju Chen, et al.
Published: (2018-11-01)

ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal
by: Choi Cheol-Hee
Published: (2005-10-01)

C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance
by: Guodong Li, et al.
Published: (2018-02-01)

Clinical and Prognostic Significance of Cell Sensitivity to Chemotherapy Detected in vitro on Treatment Response and Survival of Leukemia Patients
by: Maria Kolesnikova, et al.
Published: (2019-05-01)

The effects of ultrasound exposure on P-glycoprotein-mediated multidrug resistance in vitro and in vivo
by: Chixiong Huang, et al.
Published: (2018-09-01)

Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance
by: Yena Cho, et al.
Published: (2020-06-01)

Involvement of CD147 on multidrug resistance through the regulation of P-glycoprotein expression in K562/ADR leukemic cell line
by: Aoranit Somno, et al.
Published: (2016-01-01)

Endoplasmic reticulum stress: major player in size-dependent inhibition of P-glycoprotein by silver nanoparticles in multidrug-resistant breast cancer cells
by: Mohana Krishna Gopisetty, et al.
Published: (2019-01-01)

Pinocytosis as the Biological Mechanism That Protects Pgp Function in Multidrug Resistant Cancer Cells and in Blood–Brain Barrier Endothelial Cells
by: Ziad Omran, et al.
Published: (2020-07-01)

Multidrug resistance in Cancer: Pharmacological Strategies from Basic Research to Clinical Issues
Published: (2015)

MicroRNA-298 Reverses Multidrug Resistance to Antiepileptic Drugs by Suppressing MDR1/P-gp Expression in vitro
by: Yangmei Xie, et al.
Published: (2018-08-01)

Involvement of CUL4A in Regulation of Multidrug Resistance to P-gp Substrate Drugs in Breast Cancer Cells
by: Yunshan Wang, et al.
Published: (2013-12-01)

Multidrug resistance factor - glycoprotein P in rheumatoid arthritis
by: I P Kolosova
Published: (2003-02-01)

Cordycepin re-sensitizes multidrug resistance cancer cells to chemotherapeutic agents through modulating P-glycoprotein expression and ATPase function
by: Yu-Ning Teng, et al.
Published: (2016-10-01)

Phytochemicals reverse P-glycoprotein mediated multidrug resistance via signal transduction pathways
by: M. Ganesan, et al.
Published: (2021-07-01)

Age-related changes of the multidrug resistance P-glycoprotein function in normal human peripheral blood T lymphocytes
by: C.G. Machado, et al.
Published: (2003-12-01)

Inhibition of P-glycoprotein and multidrug resistance-associated protein 2 regulates the hepatobiliary excretion and plasma exposure of thienorphine and its glucuronide conjugate
by: Ling-Lei Kong, et al.
Published: (2016-08-01)

Multidrug resistance in tumour cells: characterisation of the multidrug resistant cell line K562-Lucena 1
by: VIVIAN M. RUMJANEK, et al.
Published: (2001-03-01)

Characterizing drug interactions in the substrate binding pocket of the P-glycoprotein multidrug efflux pump
by: Ward, David
Published: (2012)

Mitochondria P-glycoprotein confers paclitaxel resistance on ovarian cancer cells
by: Guo W, et al.
Published: (2019-05-01)

Irinotecan—Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview
by: Mateusz Kciuk, et al.
Published: (2020-07-01)

Branebrutinib (BMS-986195), a Bruton’s Tyrosine Kinase Inhibitor, Resensitizes P-Glycoprotein-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Agents
by: Chung-Pu Wu, et al.
Published: (2021-07-01)

Effect of multidrug resistance modulators on activity against Haemonchus contortus and pharmacokinetics of ivermectin and moxidectin in sheep
by: Molento, Marcelo Beltrão.
Published: (2000)

Grape seed proanthocyanidin extract reverses multidrug resistance in HL-60/ADR cells via inhibition of the PI3K/Akt signaling pathway
by: Ka-Na Lin, et al.
Published: (2020-05-01)

Screening of Natural Compounds as P-Glycoprotein Inhibitors against Multidrug Resistance
by: Sérgio M. Marques, et al.
Published: (2021-03-01)

Selecting surfactants for the maximum inhibition of the activity of the multidrug resistance efflux pump transporter, P-glycoprotein: conceptual development
by: Shireesh Apte
Published: (2010-09-01)

P-glycoprotein-mediated resistance to chemotherapy in cancer cells: using recombinant cytosolic domains to establish structure-function relationships
by: Di Pietro A., et al.
Published: (1999-01-01)

Overcoming multidrug-resistance in vitro and in vivo using the novel P-glycoprotein inhibitor 1416
by: Yan Xu, et al.
Published: (2012-10-01)